Get more replies from employers
Send a job-specific resume in minutes.
The University of North Carolina - Chapel Hill, in collaboration with the Duke Clinical Research Institute, offers a two‑year T32 Postdoctoral Training Program in Clinical Pharmacology. The program trains clinician‑scientists to lead in drug discovery, development, and individualized therapy, meeting ABCP fellowship standards.
Applicants must have completed doctoral training (MD, PharmD, or DDS) and demonstrate strong scientific writing, grant writing, and presentation skills; a robust
The UNC‑Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program is a partnership between the UNC Eshelman School of Pharmacy and the Duke Clinical Research Institute designed to prepare clinician‑scientists for leadership in clinical pharmacology research. This two‑year program meets the fellowship training expectations set by the American Board of Clinical Pharmacology and is a registered member of ABCP. The program covers drug discovery, clinical development, regulatory issues, therapeutic use and individualization of drug therapy, optimization of drug dosage regimens, understanding of drug‑induced toxicity, and measures to prevent or minimize adverse effects.
Candidate must have completed doctoral training in the pharmaceutical or medical field (M.D., Pharm.D., or D.D.S.).
Apply online at https://unc.peopleadmin.com/postings/300334 with the following documents: 1. Cover letter 2. CV/resume 3. Statement of research and career goals 4. (Optional) two letters of recommendation as "Other documents".
The University is an equal opportunity employer and welcomes all to apply without regard to age, color, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex, or sexual orientation. We encourage all qualified applicants, including protected veterans and individuals with disabilities, to apply.